You are here

  • Home
  • Archive
  • Volume 7, Issue 1
  • Worsening and newly diagnosed paraneoplastic syndromes following anti-PD-1 or anti-PD-L1 immunotherapies, a descriptive study

Article metrics

Article menu

Download PDFPDF

XML
Research Article
Worsening and newly diagnosed paraneoplastic syndromes following anti-PD-1 or anti-PD-L1 immunotherapies, a descriptive study

 

Online download statistics by month:

Online download statistics by month: January 2020 to March 2024

AbstractFullPdf
Jan 202013130
Feb 202065650
Mar 202036361
Apr 202037379
May 2020484815
Jun 2020404022
Jul 2020272712
Aug 2020404030
Sep 2020454627
Oct 2020414123
Nov 2020373724
Dec 2020434326
Jan 2021434336
Feb 2021323214
Mar 2021393924
Apr 2021363616
May 2021282823
Jun 2021303023
Jul 2021323217
Aug 2021333316
Sep 2021525227
Oct 2021565647
Nov 2021454530
Dec 2021343422
Jan 2022323316
Feb 2022273019
Mar 2022949620
Apr 2022495114
May 2022636323
Jun 2022363611
Jul 202240417
Aug 2022555517
Sep 2022505316
Oct 2022364014
Nov 2022414116
Dec 2022394112
Jan 2023525331
Feb 2023444544
Mar 2023525322
Apr 2023303013
May 2023444720
Jun 2023525323
Jul 2023616317
Aug 2023737322
Sep 20239910022
Oct 2023949412
Nov 2023767619
Dec 2023696916
Jan 2024293011
Feb 2024717116
Mar 2024919122
Total24312461979